Jaguar Health (JAGX) Other financing activities (2015 - 2023)

Jaguar Health (JAGX) posted quarterly Other financing activities of -$2000.0 for Q4 2023, down 166.67% quarter-over-quarter from $3000.0 in Q2 2023.

Jaguar Health (JAGX) Other financing activities (2015 - 2023) Analysis & Trends

Jaguar Health (JAGX) has reported Other financing activities for 9 consecutive years, with -$2000.0 the latest figure, recorded in Q4 2023.

In Q4 2023, Other financing activities changed N/A year-over-year to -$2000.0; the TTM figure through Jun 2024 stood at -$2000.0 (up 99.58% YoY), while the FY2023 annual figure was $1.2 million, changed N/A from the prior year.
Other financing activities eased to -$2000.0 in Q4 2023 per JAGX's latest filing, from $3000.0 in the prior quarter.
Across five years, Other financing activities topped out at $5.5 million in Q4 2020 and bottomed at -$1.5 million in Q4 2021.
Historically, Other financing activities has averaged $654916.7 across 5 years, with a median of $219867.0 in 2019.
Annual changes were most pronounced in 2020 — Other financing activities jumped 2249.68% — and 2021, when it tumbled 127.84%.
Jaguar Health's Other financing activities stood at $233734.0 in 2019, then surged by 2249.68% to $5.5 million in 2020, then sank by 127.84% to -$1.5 million in 2021, then soared by 88.36% to -$178000.0 in 2022, then jumped by 98.88% to -$2000.0 in 2023.
Business Quant data shows JAGX's Other financing activities at -$2000.0 in Q4 2023, $3000.0 in Q2 2023, and $1.2 million in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Jaguar Health	447,549.24	-9.62 Mn	19.11 Mn

Download Data